DAB2IP and triple-negative breast carcinoma: Importantly, similar results were obtained in the triple-negative breast cancer cell line MDA-MB-231, where disruption of the actin cytoskeleton reduced DAB2IP in low density, but had negligible effects in high-density conditions (Figure S3D,E).